Skip to main content

Advertisement

Table 1 Characteristics of the patient population (N = 100)

From: Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach

Variable Median+/-SD All patients Women Men Fragility fracture High energy trauma With contributors Without contributors
Number 100 73 27 80 20 57 43
Women/men (n) 73/27 na na 66/14 7/13** 40/17 33/10***
Caucasian ethnicity (n) 97 94 27 79 18 55 42
Age (years) 68 ± 10 70 ± 9 62 ± 8* 69,1 ± 9 63.3 ± 9** 71 ± 10 64 ± 7***
Weight (kg) 66 ± 13 63 ± 13 73 ± 11* 65,4 ± 14 68.8 ± 11 64 ± 14 69 ± 11
Spine T-score -2.88 ± .91 -2.94 ± 0.79 -2.73 ± 1.17 -2.9 ± 0.92 -2.8 ± 0.83 -2.85 ± 0.97 -2.93 ± 0.82
Hip T-score -1.92 ± 0.9 -2.13 ± 0.92 -1.37 ± 0.70* -2 ± 0.87 -1.6 ± 1.09 -2.1 ± 1.00 -0.66 ± 0.63***
Hip Z-score -1.92 ± 0.8 -0.57 ± 0.85 -0.89 ± 0.73 -0.62 ± 0.85 -0.83 ± 0.72 -0.66 ± 0.97 -0.66 ± 0.63
BMD spine(g/sq cm) 0.772+/- 0.100 0.756 ± 0.085 0.810 ± 0.130* 0.765 ± 0.103 0.795 ± 0.094 0.776 ± 0.109 0.766 ± 0.091
BMD hip(g/sq cm) 0.718+/- 0.395 0.676 ± 0.115 0.825 ± 0.107* 0.700 ± 0.116 0.779 ± 0.160** 0.695 ± 0.143 0.749 ± 0.106
Calcium intake(mg/day) 852 ± 432 828 ± 448 915 ± 389 851 ± 467 854 ± 266 744 ± 343 993 ± 497***
Serum 25OH vitamin D (nmol/L) 66 ± 53 67 ± 60 63 ± 28 63 ± 57 75 ± 30 42 0
Creatinine clearance (ml/min) 67 ± 23 62 ± 20 65 ± 23 65 ± 23 74 ± 26 45 ± 18 82 ± 24***
Fracture after fall from standing height (n) 80 66 14 na na 45 35
N of contributors (n) 86 62 24 70 16 na na
N with contributors (n) 57 40 17 45 12 na na
N with bone-related fracture risks 54 42 12 44 10 33 21
N with fall-related fracture risks 79 57 22 65 14 46 33
Time Go Up and Go (min) 8.6 ± 7.9 8.4 ± 8.0 8.9 ± 8.0 8.2 ± 8.0 9.8+/-8.0 8.1+/-8.6 9.2+/-7.1
N with MVD <0.80 (n/n measured) 53/93 35/66 18/27 42/73 11/20 36/54 17/39***
N with MVD <0.75 29 22 7 24 11 19 10
  1. *p < 0.05 women vs. men, ** p < 0.05 between fragility fracture and high-energy trauma, *** p < 0.05 between group with and without contributor, Na: not applicable